Dissecting visceral fibromuscular dysplasia reveals a new vascular phenotype of the disease: a report from the ARCADIA-POL study.
暂无分享,去创建一个
K. Zieniewicz | W. Drygas | M. Litwin | A. Januszewicz | A. Witkowski | O. Rowiński | D. Adlam | S. Nazarewski | P. Van der Niepen | P. Dobrowolski | A. Prejbisz | J. Kądziela | Ł. Olewnik | A. Persu | I. Michałowska | A. Falkowski | M. Szczerbo-trojanowska | E. Florczak | M. Januszewicz | M. Kabat | M. Pappaccogli | A. Klisiewicz | E. Warchoł-Celińska | W. Śmigielski | K. Madej | A. Soplinska | K. Pieluszczak | M. Smólski | K. Jozwik-plebanek | Cezary Zgorzelski | K. Jóźwik-Plebanek | P. van der Niepen
[1] A. Maas,et al. Arterial Tortuosity: Novel Implications for an Old Phenotype , 2019, Hypertension.
[2] M. Litwin,et al. Association of intrarenal blood flow with renal function and target organ damage in hypertensive patients with fibromuscular dysplasia: the ARCADIA-POL study. , 2019, Polish archives of internal medicine.
[3] Aditya M. Sharma,et al. First International Consensus on the diagnosis and management of fibromuscular dysplasia , 2019, Vascular medicine.
[4] S. Laurent,et al. Deep Vascular Phenotyping in Patients With Renal Multifocal Fibromuscular Dysplasia , 2019, Hypertension.
[5] P. Astarci,et al. Visceral Fibromuscular Dysplasia: From asymptomatic disorder to emergency , 2018, European journal of clinical investigation.
[6] A. Januszewicz,et al. Echocardiographic assessment of left ventricular morphology and function in patients with fibromuscular dysplasia: the ARCADIA-POL study , 2018, Journal of hypertension.
[7] P. Gosse,et al. High Prevalence of Multiple Arterial Bed Lesions in Patients With Fibromuscular Dysplasia: The ARCADIA Registry (Assessment of Renal and Cervical Artery Dysplasia) , 2017, Hypertension.
[8] R. Renapurkar,et al. Screening CT Angiography of the Aorta, Visceral Branch Vessels, and Pelvic Arteries in Fibromuscular Dysplasia. , 2017, JACC. Cardiovascular imaging.
[9] B. Kaufman,et al. Spontaneous hepatic artery dissection—a rare presentation of fibromuscular dysplasia , 2016, Oxford medical case reports.
[10] Sergio Silveira Leal Meirelles. Visceral artery aneurysms. , 2016, Revista do Colegio Brasileiro de Cirurgioes.
[11] Aditya M. Sharma,et al. Dissection and Aneurysm in Patients With Fibromuscular Dysplasia: Findings From the U.S. Registry for FMD. , 2016, Journal of the American College of Cardiology.
[12] Aditya M. Sharma,et al. Smoking and Adverse Outcomes in Fibromuscular Dysplasia: U.S. Registry Report. , 2016, Journal of the American College of Cardiology.
[13] E. Kline-Rogers,et al. Differences between the pediatric and adult presentation of fibromuscular dysplasia: results from the US Registry , 2016, Pediatric Nephrology.
[14] W. Drygas,et al. Multi-centre National Population Health Examination Survey (WOBASZ II study): assumptions, methods, and implementation. , 2015, Kardiologia polska.
[15] K. Kreitner,et al. Visceral artery aneurysms: Incidence, management, and outcome analysis in a tertiary care center over one decade , 2015, European Radiology.
[16] X. Jeunemaître,et al. Association Between 2 Angiographic Subtypes of Renal Artery Fibromuscular Dysplasia and Clinical Characteristics , 2012, Circulation.
[17] K. Eagle,et al. The United States Registry for Fibromuscular Dysplasia: Results in the First 447 Patients , 2012, Circulation.
[18] S. Berceli. Hepatic and splenic artery aneurysms. , 2005, Seminars in vascular surgery.
[19] W. Stone,et al. Hepatic artery aneurysm: factors that predict complications. , 2003, Journal of vascular surgery.
[20] P. Kurjata,et al. [Multicenter national Polish population health status tests--WOBASZ project. Establishment of methods and logistics]. , 2005, Kardiologia polska.
[21] M. Stowasser,et al. Increased severity of multifocal renal arterial fibromuscular dysplasia in smokers , 1999, Journal of Human Hypertension.